The European peptide therapeutics market is anticipated to project a CAGR of 4.3%, during the forecast period. Europe is estimated to have a significant share in the global peptide therapeutics market. The major factors that drive the growth of the market include the rising prevalence of cancer, geriatric population coupled with the increased investments in the healthcare sector across the major economies of the region.
Get Free Sample link @ https://www.omrglobal.com/request-sample/european-peptide-therapeutics-market
The European peptide therapeutics market is segmented on the basis of route of administration and application. Based on the route of administration, the market is bifurcated into parenteral administration and oral administration. On the basis of application, the market is segmented into cancer, metabolic disorder (diabetes & obesity), gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others including chronic kidney diseases, osteoporosis, and autoimmune disorder. Among these applications, metabolic disorder dominates the market in Europe. The increasing prevalence of diabetes globally created demand for insulin and hence drives the market growth.
A full report of European Peptide Therapeutics Market available @ https://www.omrglobal.com/industry-reports/european-peptide-therapeutics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
European Peptide Therapeutics Market by Route of Administration
- Oral
- Parenteral
European Peptide Therapeutics Market by Application
- Cancer
- Metabolic Disorder
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others (Kidney Disorder and Autoimmune Disorder)
Regional Analysis
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
Company Profiles
- AstraZeneca PLC
- Overview
- AstraZeneca Plc in Europe
- AstraZeneca Plc in Peptide Therapeutics Landscape
- Recent Developments
- BachemHolding AG
- CordenPharmaInternational GmbH
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
The Report Covers:
- Comprehensive research methodology of the European peptide therapeutics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the European peptide therapeutics market.
- Insights about market determinants which are stimulating the European peptide therapeutics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-peptide-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
